Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Relay Therapeutics, Inc. |
|---|---|
| Ticker | RLAY |
| CIK | 0001812364 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Relay Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-24 02:41:19.470441 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -17,717 | 10.06 | -178,233.02 | -209,0% | |
| 2026-01-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -2,686 | 8.45 | -22,696.70 | -26,6% | |
| 2026-01-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -2,686 | 8.45 | -22,696.70 | -26,6% | |
| 2026-01-28 | Rahmer Peter | Officer, See remarks | Open Market Sale | -1,354 | 8.45 | -11,441.30 | -13,4% | |
| 2026-01-28 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -1,695 | 8.45 | -14,322.75 | -16,8% | |
| 2026-01-27 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -13,820 | 7.62 | -105,308.40 | -123,5% | |
| 2026-01-27 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -18,895 | 7.62 | -143,979.90 | -168,9% | |
| 2026-01-27 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -18,895 | 7.62 | -143,979.90 | -168,9% | |
| 2026-01-27 | Rahmer Peter | Officer, See remarks | Open Market Sale | -11,684 | 7.62 | -89,032.08 | -104,4% | |
| 2026-01-06 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -43,168 | 7.82 | -337,573.76 | -395,9% | |
| 2025-11-03 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -62,073 | 7.00 | -434,511.00 | -509,6% | |
| 2025-10-29 | Rahmer Peter | Officer, See remarks | Open Market Sale | -21,394 | 7.50 | -160,455.00 | -188,2% | |
| 2025-10-28 | Rahmer Peter | Officer, See remarks | Open Market Sale | -19,135 | 7.29 | -139,494.15 | -163,6% | |
| 2025-10-28 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -21,664 | 7.29 | -157,930.56 | -185,2% | |
| 2025-10-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -30,897 | 7.29 | -225,239.13 | -264,2% | |
| 2025-10-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -30,897 | 7.29 | -225,239.13 | -264,2% | |
| 2025-07-29 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -26,701 | 3.68 | -98,259.68 | -115,2% | |
| 2025-07-29 | Rahmer Peter | Officer, See remarks | Open Market Sale | -15,724 | 3.68 | -57,864.32 | -67,9% | |
| 2025-07-29 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -26,701 | 3.68 | -98,259.68 | -115,2% | |
| 2025-07-29 | Adams Brian | Officer, Chief Legal Officer | Open Market Sale | -18,276 | 3.68 | -67,255.68 | -78,9% | |
| 2025-07-29 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -18,380 | 3.68 | -67,638.40 | -79,3% | |
| 2025-07-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -4,069 | 3.74 | -15,218.06 | -17,8% | |
| 2025-07-28 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -1,701 | 3.74 | -6,361.74 | -7,5% | |
| 2025-07-28 | Rahmer Peter | Officer, See remarks | Open Market Sale | -1,359 | 3.74 | -5,082.66 | -6,0% | |
| 2025-07-28 | Adams Brian | Officer, Chief Legal Officer | Open Market Sale | -1,637 | 3.74 | -6,122.38 | -7,2% | |
| 2025-07-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -4,069 | 3.74 | -15,218.06 | -17,8% | |
| 2025-07-09 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -42,740 | 3.57 | -152,581.80 | -178,9% | |
| 2025-07-09 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -18,639 | 3.57 | -66,541.23 | -78,0% | |
| 2025-04-30 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -12,943 | 3.00 | -38,829.00 | -45,5% | |
| 2025-04-30 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -27,472 | 3.00 | -82,416.00 | -96,7% | |
| 2025-04-30 | Adams Brian | Officer, Chief Legal Officer | Open Market Sale | -12,943 | 3.00 | -38,829.00 | -45,5% | |
| 2025-04-30 | Rahmer Peter | Officer, See remarks | Open Market Sale | -10,739 | 3.00 | -32,217.00 | -37,8% | |
| 2025-04-30 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -27,472 | 3.00 | -82,416.00 | -96,7% | |
| 2025-04-29 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -3,558 | 3.23 | -11,492.34 | -13,5% | |
| 2025-04-28 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -981 | 3.17 | -3,109.77 | -3,6% | |
| 2025-04-28 | Rahmer Peter | Officer, See remarks | Open Market Sale | -1,364 | 3.17 | -4,323.88 | -5,1% | |
| 2025-04-28 | Adams Brian | Officer, Chief Legal Officer | Open Market Sale | -1,644 | 3.17 | -5,211.48 | -6,1% | |
| 2025-04-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -4,090 | 3.17 | -12,965.30 | -15,2% | |
| 2025-04-28 | Bergstrom Donald A | Officer, President, R&D | Open Market Sale | -4,090 | 3.17 | -12,965.30 | -15,2% | |
| 2025-04-28 | Catinazzo Thomas | Officer, Chief Financial Officer | Open Market Sale | -1,709 | 3.17 | -5,417.53 | -6,4% | |
| 2025-04-23 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -18,653 | 2.97 | -55,399.41 | -65,0% | |
| 2025-04-23 | Patel Sanjiv | Director, Officer, President and CEO | Open Market Sale | -42,769 | 2.97 | -127,023.93 | -149,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.